SynthesisActa diabetologica2026

Efficacy and safety of orforglipron in type 2 diabetes mellitus and obesity: a GRADE-assessed meta-analysis and trial sequential analysis with subgroup evaluations by diabetic status, obesity status, and dose regimens.

Asad Jamal et al.PubMed ↗Publisher ↗

No numbers read from the abstract.